| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing DNA medicines for treating and protecting against HPV-related diseases, cancer, and infectious diseases. The company employs proprietar..
>Volltext.. |
| 104.15 Mio. EUR |
| 62.32 Mio. EUR |
| 0.06 Mio. EUR |
| -72.63 Mio. EUR |
| -73.59 Mio. EUR |
| -1.67 EUR |
| 8.12 Mio. EUR |
| 38.35 Mio. EUR |
| -76.78 Mio. EUR |
| 1.34 |
| -73.55% |
| 30.19% |
| - |
| - |
| - |
| - |
| INOVIO |
| 05.04.26 |
|